Login

Register

Login

Register

Home

The Brainclinics Foundation

History

Brainclinics was founded in 2001 as an independent research institute by dr. Martijn Arns and specializes in advancing our understanding of the brain. The results of our research are a valuable aid in the treatment and prevention of symptoms such as mood-, concentration-, impulse control-, and sleep problems, often seen in disorders such as depression, ADHD, and insomnia. Over the last 20 years, Brainclinics has pioneered the application of neurofeedback in the treatment of ADHD and insomnia, was one of the first to recognize the importance of the circadian clock and sleep problems underlying many symptoms like impaired concentration and impulse control, specifically in ADHD, while also pioneering and refining magnetic brain stimulation (rTMS) in the treatment of depression and obsessive–compulsive disorder (OCD). In 2019 the legal structure was changed, and the non-profit Brainclinics Foundation was established. The Brainclinics Foundation’s primary mission is best summarized as: Applied Neuroscience from the clinic, to the clinic. Therefore, the two pillars of the foundation are formed by Research Institute Brainclinics and Brainclinics Insights (the publishing division).

Research

At Research Institute Brainclinics researchers have published over 170 scientific publications on these and related topics and continue to collaborate with researchers and universities around the world ranging from Australia, Germany, Belgium, the United States to Colombia. A key topic of our research revolves around ‘personalized medicine’, going beyond the traditional ‘diagnostic-thinking’ and focusing on individual differences that can help optimize and individualize treatment and prevent symptoms from occurring. Our research has resulted in 4 patents and several spin-offs, such as Brainquiry, where the first ever wireless Bluetooth based EEG amplifier was developed in 2003 and the first wrist-worn heart-rate device in 2005 (nine years before Apple launched the Apple Watch with similar technology). Other spin-offs are Brainclinics Education, where specialistic applied neuroscience training courses were developed focused on rTMS, neurofeedback and QEEG, and Brainclinics Treatment, where our unequalled knowledge and expertise on personalized neuromodulation treatments are applied to benefit people worldwide. In 2015, Brainclinics Education and Brainclinics Treatment were acquired by the neuroCare Group, where courses are still taught by neuroCademy, and neuromodulation treatments that followed from Brainclinics Research are offered in >15 neuroCare clinics worldwide.

Publishing

Brainclinics Insights is the publishing division of our foundation. Its mission is to make the knowledge, expertise and especially ‘Insights’ gained through our research, widely available through books, PhD theses and interactive media.

To serve the goal of the Brainclinics Foundation, all proceeds are fully invested into Research Institute Brainclinics and Brainclinics Insights, which creates an unprecedented synergy between these divisions and makes it possible to perform research and share new future insights as well.

At the Brainclinics Foundation, it is all about the research and its application!

Our latest EEG neurofeedback study is out in Neuroimage Clinical, with some unexpected results in adult ADHD patients!
https://www.sciencedirect.com/science/article/pii/S2213158219304917 thread 1/7

News on the Birbaumer scientific misconduct case. Open letter in his defense signed by well respected international scholars. There is a whole webpage dedicated to his defense here: http://www.communication4als.com/gallery. In case you want to check it out... #birbaumer #retraction #ALS

The 2020 update of the Lefaucheur et al. Evidence-based rTMS guidelines.
HF, LF and dTMS in MDD still main psychiatric indication.
Emerging applications in this edition: Fibromyalgia, Motor Stroke, MS, AD and PTSD
https://buff.ly/2sR9mGS

Mixing Apples and Oranges in Assessing Outcomes of rTMS Meta-Analyses: Response to Amad et al's claim that rTMS studies are underpowered.
https://buff.ly/36IsFR5

Like many of you, I received a DMCA removal request by the @APA a few days ago, asking me to remove the PDF of a paper from my personal website.

I wrote them back, & they have rescinded their request. I'll post screenshots of the emails below and hope it helps others.

Depressie-behandelingen te individualiseren door verbinding tussen hart en hersenen: Interview met Dr. Tabitha Iseger over de Neuro-Cardiac-Guided TMS (NCG TMS)
https://buff.ly/36LvVLf

Load More...